PedAM
Pediatric Disease Annotations & Medicines
| Disease | mucormycosis |
| Phenotype | C0011849|diabetes mellitus |
| Sentences | 7 |
| PubMedID- 26038425 | Important immunosuppressive conditions associated with mucormycosis include diabetes mellitus, hematological malignancies, use of corticosteroids and other immunosuppressive agents in transplant recipients and severe burn patients.1,2 due to the increasing use of immunosuppressive agents and prolonged survival of these patients, mucormycosis is becoming increasingly common, but mortality remains very high, often above 50%.3 the common clinical manifestations of mucormycosis are rhinocerebral, pulmonary, gastrointestinal and cutaneous, depending on the routes of infection. |
| PubMedID- 25750854 | Over the last 10 years there has been a surge in predisposing factors for mucormycosis, with diabetes mellitus being the most common underlying disorder in an estimated 70% of cases of mucor and renal disease being the second most common risk factor [7]. |
| PubMedID- 20606975 | [6] we describe a case of post-surgical intestinal and surgical wound mucormycosis in patient with well-controlled diabetes mellitus. |
| PubMedID- 22779014 | Rhinocerebral mucormycosis, often associated with diabetes mellitus. |
| PubMedID- 23055648 | But a decreasing number of published mucormycosis since 1990 in patients with diabetes mellitus was reported by some authors. |
| PubMedID- 20378023 | Our case suggests the importance of suspecting a mucormycosis infection in patients with decompensated diabetes mellitus, even without ketoacidosis. |
| PubMedID- 21308550 | mucormycosis typically occurs in patients with diabetes mellitus, organ or hematopoietic stem cell transplantation (hsct), neutropenia, or malignancy [2, 3]. |
Page: 1